BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33430982)

  • 1. ACID: a free tool for drug repurposing using consensus inverse docking strategy.
    Wang F; Wu FX; Li CZ; Jia CY; Su SW; Hao GF; Yang GF
    J Cheminform; 2019 Nov; 11(1):73. PubMed ID: 33430982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIMMS suite: a web server dedicated for prediction of drug resistance on protein mutation.
    Wu FX; Wang F; Yang JF; Jiang W; Wang MY; Jia CY; Hao GF; Yang GF
    Brief Bioinform; 2020 Jan; 21(1):318-328. PubMed ID: 30496338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HISNAPI: a bioinformatic tool for dynamic hot spot analysis in nucleic acid-protein interface with a case study.
    Mei LC; Wang YL; Wu FX; Wang F; Hao GF; Yang GF
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACFIS: a web server for fragment-based drug discovery.
    Hao GF; Jiang W; Ye YN; Wu FX; Zhu XL; Guo FB; Yang GF
    Nucleic Acids Res; 2016 Jul; 44(W1):W550-6. PubMed ID: 27150808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIIMS Server: A Web Server for Mutation Hotspot Scanning at the Protein-Protein Interface.
    Wu FX; Yang JF; Mei LC; Wang F; Hao GF; Yang GF
    J Chem Inf Model; 2021 Jan; 61(1):14-20. PubMed ID: 33400510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRDS: Consensus Reverse Docking System for target fishing.
    Lee A; Kim D
    Bioinformatics; 2020 Feb; 36(3):959-960. PubMed ID: 31432077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auto In Silico Ligand Directing Evolution to Facilitate the Rapid and Efficient Discovery of Drug Lead.
    Wu F; Zhuo L; Wang F; Huang W; Hao G; Yang G
    iScience; 2020 Jun; 23(6):101179. PubMed ID: 32498019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACFIS 2.0: an improved web-server for fragment-based drug discovery via a dynamic screening strategy.
    Shi XX; Wang ZZ; Wang F; Hao GF; Yang GF
    Nucleic Acids Res; 2023 Jul; 51(W1):W25-W32. PubMed ID: 37158247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive Reliability Evaluation of Docking-Based Target-Fishing Strategies.
    Lapillo M; Tuccinardi T; Martinelli A; Macchia M; Giordano A; Poli G
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential target of Tanshinone IIA for acute promyelocytic leukemia revealed by inverse docking and drug repurposing.
    Chen SJ
    Asian Pac J Cancer Prev; 2014; 15(10):4301-5. PubMed ID: 24935388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LigTMap: ligand and structure-based target identification and activity prediction for small molecular compounds.
    Shaikh F; Tai HK; Desai N; Siu SWI
    J Cheminform; 2021 Jun; 13(1):44. PubMed ID: 34112240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HawkDock: a web server to predict and analyze the protein-protein complex based on computational docking and MM/GBSA.
    Weng G; Wang E; Wang Z; Liu H; Zhu F; Li D; Hou T
    Nucleic Acids Res; 2019 Jul; 47(W1):W322-W330. PubMed ID: 31106357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRDS: a web server for evaluating drug resistance mutations in kinases by molecular docking.
    Lee A; Hong S; Kim D
    J Cheminform; 2018 Apr; 10(1):20. PubMed ID: 29633047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Preparation Automatic Protocol for High-Throughput Inverse Virtual Screening: Accelerating the Target Identification by Computational Methods.
    De Vita S; Lauro G; Ruggiero D; Terracciano S; Riccio R; Bifulco G
    J Chem Inf Model; 2019 Nov; 59(11):4678-4690. PubMed ID: 31593460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repurposing from the perspective of pharmaceutical companies.
    Cha Y; Erez T; Reynolds IJ; Kumar D; Ross J; Koytiger G; Kusko R; Zeskind B; Risso S; Kagan E; Papapetropoulos S; Grossman I; Laifenfeld D
    Br J Pharmacol; 2018 Jan; 175(2):168-180. PubMed ID: 28369768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPEPDOCK: a web server for blind peptide-protein docking based on a hierarchical algorithm.
    Zhou P; Jin B; Li H; Huang SY
    Nucleic Acids Res; 2018 Jul; 46(W1):W443-W450. PubMed ID: 29746661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDOCK: a web server for protein-protein and protein-DNA/RNA docking based on a hybrid strategy.
    Yan Y; Zhang D; Zhou P; Li B; Huang SY
    Nucleic Acids Res; 2017 Jul; 45(W1):W365-W373. PubMed ID: 28521030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Repurposing of Old Drugs or Unsuccessful Lead Compounds by in Silico Approaches: New Advances and Perspectives.
    Martorana A; Perricone U; Lauria A
    Curr Top Med Chem; 2016; 16(19):2088-106. PubMed ID: 26881716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.